Jin Cheng

10.0k citations
118 papers · 7.6k · 3 hit papers · h-index 44

Impact in

    • MicroRNA in disease regulation
  • Oncology top 1%
    • Cytokine Signaling Pathways and Interactions
    • Cancer-related Molecular Pathways

Papers in

    • Advanced biosensing and bioanalysis techniques 15
    • RNA Interference and Gene Delivery 14
    • Cell death mechanisms and regulation 11
    • PI3K/AKT/mTOR signaling in cancer 9
    • Cancer-related Molecular Pathways 7
    • Cytokine Signaling Pathways and Interactions 5

Jin Cheng

115 papers receiving 7.5k citations

Jin Cheng's Hit Papers

Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer 2020 · 364 citations
3640+7+14Years since publication200400600

Peers

Jin Cheng
Comparison fields: 5 of 131
  • Cancer Research 1.2k
  • Oncology 1.9k
  • Molecular Biology 3.9k
  • Immunology 866
  • Cell Biology 501
Replace Nathan R. Wall with:
Nathan R. Wall United States
Jinming Yang United States
Frank A.E. Kruyt Netherlands
Carlos Garcı́a-Echeverrı́a Switzerland
Grazia Ambrosini United States
Gavin P. Robertson United States
Joji Kitayama Japan
Mitsuhiko Osaki Japan
Y. Eugene Chin United States
Michelle Haber Australia
Jin Cheng relative to Nathan R. Wall United States Nathan R. Wall's profile →
Citations per field
00.5×3.2×
Nathan R. Wall · 1×
Citations per year

Countries citing papers authored by Jin Cheng

Since Specialization
Citations

This map shows the geographic impact of Jin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Cheng more than expected).

Fields of papers citing papers by Jin Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Cheng. The network helps show where Jin Cheng may publish in the future.

Co-authors

The 25 scholars most cited alongside Jin Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jin Cheng Line = papers co-authored together Jin Cheng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis
Hit paper breakdown →
2007725
2
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
Hit paper breakdown →
2005493
3 2006467
4
Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer
Hit paper breakdown →
2020364
5 2005309
6
Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.
2001293
7
p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.
1994278
8 1998260
9 2017243
10 2005242
11 2008237
12 2008215
13 2000198
14 2014152
15 2019124
16 1997111
17 2017105
18 201693
19 201792
20
Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway.
200392

About Jin Cheng

Jin Cheng is a scholar working on Molecular Biology, Oncology, Cancer Research, Biomedical Engineering and Surgery, having authored 118 papers that have together received 7.6k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (15 papers), RNA Interference and Gene Delivery (14 papers), Cell death mechanisms and regulation (11 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Nanoplatforms for cancer theranostics (8 papers), Cancer-related Molecular Pathways (7 papers), MicroRNA in disease regulation (6 papers) and Cytokine Signaling Pathways and Interactions (5 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.9k citations), Molecular Biology (3.9k citations), Immunology (866 citations) and Cell Biology (501 citations). Jin Cheng has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Domenico Coppola, Richard Jove, Mei Sun, Joseph R. Testa, Ling Tian, Qian Huang, James Turkson, Sijia He, Chuan‐Yuan Li and Sangkil Nam. Their work appears in journals such as Cancer Research, Genes Chromosomes and Cancer, Experimental Cell Research, Oncogene and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact